×
News
December 12, 2014

New Paradigm for Transparency Practice for Greater Openness and Accountability in the Pharmaceutical Sector in Europe

Bloomberg BNA's Life Sciences Law & Industry Report
By Lincoln Tsang Jacqueline Mulryne Silvia Valverde
Find more content tagged:

Stay up-to-date with the latest topics from the firm.

Email Subscriptions RSS Feed (All Perspectives) RSS Feed (News Only)

People

Lincoln Tsang
Lincoln Tsang
Partner
London
+44 (0)20 7786 6104
lincoln.tsang@arnoldporter.com
VCard
Jacqueline Mulryne
Jacqueline Mulryne
Counsel
London
+44 (0)20 7786 6123
jacqueline.mulryne@arnoldporter.com
VCard
Silvia Valverde
Silvia Valverde
Professional Support Lawyer
London
+44 (0)20 7786 6165
silvia.valverde@arnoldporter.com
VCard

Related Articles

May 14, 2018
FDA and USDA Action Implements US Nutrition Action Plan and Federal Food Labeling Policy Agenda
Advisory
May 14, 2018
Trump Administration Issues Blueprint to Lower Drug Prices and Reduce Out-Of-Pocket Costs
Advisory
May 10, 2018
Is the EU Product Liability Directive still fit for purpose?
BioSlice Blog

Email Disclaimer

Reject Accept